FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080856095> ?p ?o ?g. }

• W2080856095 endingPage "224" @default.
• W2080856095 startingPage "217" @default.
• W2080856095 abstract "To assess the efficacy and safety of olanzapine/fluoxetine combination (OFC) for the acute treatment of bipolar depression in children and adolescents.Patients 10 to 17 years of age with bipolar I disorder (BP-I), depressed episode, baseline Children's Depression Rating Scale-Revised (CDRS-R) total score ≥40, Young Mania Rating Scale (YMRS) total score ≤15, and YMRS-item 1 ≤2 were randomized to OFC (6/25-12/50 mg/day olanzapine/fluoxetine; n = 170) or placebo (n = 85) for up to 8 weeks of double-blind treatment. The primary efficacy measure was mean change in CDRS-R using mixed-model repeated-measures methodology.Baseline-to-week-8 least-squares mean change in CDRS-R total score was greater for OFC-treated patients than for placebo-treated patients (-28.4 versus -23.4, p = .003; effect size = .46), with between-group differences statistically significant at week 1 (p = .02) and all subsequent visits (all p < .01). Rates of and times to response and remission were statistically significantly greater for OFC- than for placebo-treated patients. The most frequent treatment-emergent adverse events in the OFC group were weight gain, increased appetite, and somnolence. Mean weight gain at patient's endpoint was significantly greater for OFC- than for placebo-treated patients (4.4 kg versus 0.5 kg, p < .001). Treatment-emergent hyperlipidemia was very common among OFC-treated patients. Abnormal increases in hepatic analytes, prolactin, and corrected QT interval (QTc) were also common or very common but generally not clinically significant.In this study, OFC was superior to placebo, and has been approved by the US Food and Drug Administration (FDA) for the acute treatment of bipolar I depression in patients 10 to 17 years of age. Benefits should be weighed against the risk of adverse events, particularly weight gain and hyperlipidemia. Clinical trial registration information-A Study for Assessing Treatment of Patients Ages 10-17 with Bipolar Depression; http://clinicaltrials.gov; NCT00844857." @default.
• W2080856095 created "2016-06-24" @default.
• W2080856095 creator A5005949780 @default.
• W2080856095 creator A5013740415 @default.
• W2080856095 creator A5068884979 @default.
• W2080856095 creator A5077713434 @default.
• W2080856095 date "2015-03-01" @default.
• W2080856095 modified "2023-10-14" @default.
• W2080856095 title "Olanzapine/Fluoxetine Combination in Children and Adolescents With Bipolar I Depression: A Randomized, Double-Blind, Placebo-Controlled Trial" @default.
• W2080856095 cites W1969345212 @default.
• W2080856095 cites W1973061797 @default.
• W2080856095 cites W1977866915 @default.
• W2080856095 cites W1983302342 @default.
• W2080856095 cites W1996529676 @default.
• W2080856095 cites W1999689270 @default.
• W2080856095 cites W2007929837 @default.
• W2080856095 cites W2010928240 @default.
• W2080856095 cites W2011797837 @default.
• W2080856095 cites W2030034545 @default.
• W2080856095 cites W2052626672 @default.
• W2080856095 cites W2062800220 @default.
• W2080856095 cites W2071794120 @default.
• W2080856095 cites W2090844409 @default.
• W2080856095 cites W2093514511 @default.
• W2080856095 cites W2103879771 @default.
• W2080856095 cites W2106992945 @default.
• W2080856095 cites W2107955070 @default.
• W2080856095 cites W2109442247 @default.
• W2080856095 cites W2110962760 @default.
• W2080856095 cites W2111355579 @default.
• W2080856095 cites W2113208497 @default.
• W2080856095 cites W2114693958 @default.
• W2080856095 cites W2114807890 @default.
• W2080856095 cites W2125094332 @default.
• W2080856095 cites W2127549590 @default.
• W2080856095 cites W2128654468 @default.
• W2080856095 cites W2129069620 @default.
• W2080856095 cites W2135399947 @default.
• W2080856095 cites W2163880309 @default.
• W2080856095 cites W2165379748 @default.
• W2080856095 cites W2167659819 @default.
• W2080856095 cites W2169192603 @default.
• W2080856095 cites W2330720191 @default.
• W2080856095 cites W4211262802 @default.
• W2080856095 doi "https://doi.org/10.1016/j.jaac.2014.12.012" @default.
• W2080856095 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25721187" @default.
• W2080856095 hasPublicationYear "2015" @default.
• W2080856095 type Work @default.
• W2080856095 sameAs 2080856095 @default.
• W2080856095 citedByCount "56" @default.
• W2080856095 countsByYear W20808560952015 @default.
• W2080856095 countsByYear W20808560952016 @default.
• W2080856095 countsByYear W20808560952017 @default.
• W2080856095 countsByYear W20808560952018 @default.
• W2080856095 countsByYear W20808560952019 @default.
• W2080856095 countsByYear W20808560952020 @default.
• W2080856095 countsByYear W20808560952021 @default.
• W2080856095 countsByYear W20808560952022 @default.
• W2080856095 countsByYear W20808560952023 @default.
• W2080856095 crossrefType "journal-article" @default.
• W2080856095 hasAuthorship W2080856095A5005949780 @default.
• W2080856095 hasAuthorship W2080856095A5013740415 @default.
• W2080856095 hasAuthorship W2080856095A5068884979 @default.
• W2080856095 hasAuthorship W2080856095A5077713434 @default.
• W2080856095 hasBestOaLocation W20808560951 @default.
• W2080856095 hasConcept C118552586 @default.
• W2080856095 hasConcept C126322002 @default.
• W2080856095 hasConcept C139719470 @default.
• W2080856095 hasConcept C142724271 @default.
• W2080856095 hasConcept C15744967 @default.
• W2080856095 hasConcept C162324750 @default.
• W2080856095 hasConcept C168563851 @default.
• W2080856095 hasConcept C170493617 @default.
• W2080856095 hasConcept C197934379 @default.
• W2080856095 hasConcept C204787440 @default.
• W2080856095 hasConcept C27081682 @default.
• W2080856095 hasConcept C2775864247 @default.
• W2080856095 hasConcept C2776134451 @default.
• W2080856095 hasConcept C2776174506 @default.
• W2080856095 hasConcept C2776412080 @default.
• W2080856095 hasConcept C2776466505 @default.
• W2080856095 hasConcept C2776619155 @default.
• W2080856095 hasConcept C2776809841 @default.
• W2080856095 hasConcept C2776867660 @default.
• W2080856095 hasConcept C2777089681 @default.
• W2080856095 hasConcept C2778541603 @default.
• W2080856095 hasConcept C2779034229 @default.
• W2080856095 hasConcept C2779144063 @default.
• W2080856095 hasConcept C2780051608 @default.
• W2080856095 hasConcept C71924100 @default.
• W2080856095 hasConceptScore W2080856095C118552586 @default.
• W2080856095 hasConceptScore W2080856095C126322002 @default.
• W2080856095 hasConceptScore W2080856095C139719470 @default.
• W2080856095 hasConceptScore W2080856095C142724271 @default.
• W2080856095 hasConceptScore W2080856095C15744967 @default.
• W2080856095 hasConceptScore W2080856095C162324750 @default.
• W2080856095 hasConceptScore W2080856095C168563851 @default.
• W2080856095 hasConceptScore W2080856095C170493617 @default.

• next